On ECHEMI
Home > Drugs > Aniracetam Capsules

Aniracetam Capsules

Function and Efficacy

This product is a cyclized derivative of gamma-aminobutyric acid (GABA). It has the ability to resist hypoxia in the cortex and protect learning and memory loss caused by various chemicals, including hypercapnia, scopolamine or electric shock, but it has no sedative or excitatory effect, nor does it have a vasodilatory effect. Animal experiments have also shown that this product works partly by protecting the function of cholinergic neurons, which can protect the brain from the decrease of acetylcholine and memory loss caused by scopolamine, and can also stimulate the reabsorption of choline by the presynaptic membrane and accelerate the synthesis of acetylcholine.

Ingredients

Aniracetam. Chemical name: 1-(4-methoxybenzoyl)-2-pyrrolidone.

Name Description Content CAS NO. Manufacturer
AniracetamIngredients

It is a cyclized derivative of gamma-aminobutyric acid (GABA). It has the ability to resist hypoxia in the cortex and protect learning and memory loss caused by various chemicals, including hypercapnia, scopolamine or electric shock, but it has no sedative or excitatory effect, nor does it have a vasodilatory effect. It works partly by protecting the function of cholinergic neurons, which can protect the brain from the decrease of acetylcholine and memory loss caused by scopolamine, and can also stimulate the reabsorption of choline by the presynaptic membrane and accelerate the synthesis of acetylcholine.

More
72432-10-1 11

Appearance

This product is a capsule, and the contents are white to off-white powder.

Indication

1. Vascular dementia and Alzheimer's disease with mild to moderate learning, memory and cognitive dysfunction. 2. Mild to moderate cognitive and behavioral disorders after stroke. 3. Benign memory impairment in middle-aged and elderly people.

Usage and Dosage

Oral administration, 0.2g (2 tablets) at a time, 3 times a day, for 1 to 2 months, or as directed by a doctor. The dosage and course of treatment may be increased or decreased as appropriate depending on the condition and the reaction after taking the medicine.

Adverse Reactions

Adverse reactions may include dry mouth, loss of appetite, constipation, dizziness, and drowsiness, which disappear after stopping the drug. Occasionally, there are reports of excitement, restlessness, and systemic rash.

Precautions

Patients who are allergic to this product or cannot tolerate other pyrrolidone drugs should avoid using it.

Drug Interactions

Not yet clear.

Storage

Keep away from light and store in a sealed container.

Packaging Specification

0.1 g

Manufacturer

Nanjing Sanhome Pharmaceutical Co., Ltd.

  • Founded in:

    1996-09-19
  • Address:

    No. 9 Huizhong Road, Nanjing Economic and Technological Development Zone
  • Tax NO.:

    91320192608959455D
  • Registered Funds:

    430 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.